Celcuity Inc. (CELC) stock

CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30

$64.37+0.20 (+0.31%)

Close on Nov 13, 2026Market cap $3.15BP/E –Yield –

Celcuity pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Celcuity has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?